Trial Profile
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Roxadustat in Patients With Acute ST Elevation Myocardial Infarction
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2023
Price :
$35
*
At a glance
- Drugs Roxadustat (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms ROXAMI
- 16 Mar 2021 Status changed from not yet recruiting to recruiting.
- 30 Nov 2020 New trial record